• nBee
    link
    23 years ago

    From the linked article, Oxford University’s statement :

    Guidance for organisations seeking to licence or otherwise access University of Oxford IP relevant to the COVID-19 pandemic

    1. OU and OUI will expedite access to Oxford IP to enable global deployment at scale of associated products and services to address the COVID-19 pandemic
    2. The default approach of the University and OUI regarding (1) will be to offer non-exclusive, royalty-free licences to support free of charge, at-cost or cost + limited margin supply as appropriate and only for the duration of the pandemic, as defined by the WHO
    3. Licence terms for supplying downstream (post-pandemic) commercial markets will be the subject of a separate agreement
    4. The grant to a Licensee of access to IP under (1) does not guarantee it will be granted downstream commercial rights
    5. Where relevant University IP is licensed to support commercial sales after the point at which the pandemic is declared by the WHO (or other appropriate body) to be over, such licences will carry appropriate financial terms to allow the University to reinvest proceeds in research and teaching.